Summary Activation of the RET tyrosine kinase domain occurs in a proportion of thyroid papillary carcinomas. Three chromosomal rearrangements have been described, of which PTCJ is the commonest. Wide differences (2.5-25%) in frequency of PTCJ in different populations have been reported; it is not clear whether these are due to environmental factors, racial differences or technical reasons. We have developed a simple and rapid reverse transcriptase nested polymerase chain reaction (RT-nPCR) method enabling the detection of gene expression from single 5 pm sections of formalin-fixed paraffin wax-embedded archival material. We have applied this approach to detect expression of the RET tyrosine kinase domain, allowing identification of RET activation resulting from any rearrangement, whether characterised or not, or from overexpression. A retrospective study was performed on 22 adult and 21 childhood papillary carcinomas. Thirteen of 22 (59%) adult and 10 of 21 (48%) childhood carcinomas showed evidence of RET activation, demonstrating a major role for the RET oncogene in UK thyroid papillary carcinogenesis. This study also shows a similar frequency of RET activation in both children and adults. The use of a technique that allows reliable amplification of RNA from archival material, using primers chosen in different exons so that amplified products are readily distinguished from genomic DNA, will allow correlation of translocations and chromosomal rearrangements with a variety of specific tumour types.
Several neoplasms are associated with chromosomal translocations or rearrangements that fuse two unrelated genes. Whereas oncogene point mutations commonly occur in a range of tumour types, translocations are often restricted to specific tumour types, for example in the lymphomas and leukaemias (Dalla-Favera et al., 1982; Bartram et al., 1983) . More recently translocations have been characterised in solid tumours including sarcomas and here too they can be specific for one morphological type, for example myxoid liposarcoma, alveolar rhabdomyosarcoma and Ewings sarcoma, each with their own distinct fusion gene found in all or nearly all tumours (Crozat et al., 1993; Galili et al., 1993; Zucman et al., 1993; Schoenmakers et al., 1995) . Other chromosomal rearrangements such as the RET rearrangement although restricted to thyroid papillary carcinoma have been found in only a proportion of cases. The possibility that chromosomal translocations or rearrangements may define tumours with different aetiologies, morphology and clinical outcome needs to be explored.
The RET proto-oncogene encodes for a protein structurally related to the transmembrane receptors with a tyrosine kinase domain but its putative ligand is unknown (Takahashi and Cooper, 1987; Takahashi et al., 1988) . The gene is expressed in a number of cell lineages of the developing peripheral and central nervous system as well as in the excretory system (Pachnis et al., 1993) and has been described in three hereditary cancer syndromes (Donis-Keller et al., 1993; Mulligan et al., 1993; Carlson et al., 1994; Eng et al., 1994; Hofstra et al., 1994) . RET proto-oncogene expression has not been detected in normal follicular cells, (Fabien et al., 1992) 5' terminal region of another gene H4 (Grieco et al., 1990; Pierotti et al., 1992) . Other studies have reported different frequencies of the RET/PTCJ rearrangement in papillary carcinomas from different populations. Lower percentages were noted in patients with papillary carcinomas from the United States, Japan and Saudi Arabia with 11%, 9% and 2.5% respectively Jhiang et al., 1991; Zou et al., 1994) . However some of these studies involved only relatively small numbers of cases, a limitation imposed by the requirement for fresh tissue for molecular biological analysis. Most of these studies appear to have examined tumours from adults and make no reference to childhood tumours. Two additional but less frequent forms of chromosomal rearrangement have been reported with fusion of the RET tyrosine kinase coding region to the amino terminus of two other heterologous genes, the receptor for cAMP type 1 in RET/PTC2 and ELEl in RET/PTC3 (Bongarzone et al., 1993; Santoro et al., 1994 showing the position of the same primers as in A, giving rise to a 90bp first round PCR amplification product that forms the template for a second round in-nested PCR amplification product of 76 bp. Amplification of genomic DNA is therefore easily distinguished from the amplification of cDNA, because of a more than 15-fold difference in product size. for RET activation using the RT-nPCR method. A total of 13 of 22 adult and 10 of 21 childhood papillary carcinomas showed RET activation proven by the presence of a PCR product of the predicted size ( Figure 2 ) and confirmed by the identification of the specific cDNA RET TK sequence using direct solid-phase sequencing (Figure 3) . The results are shown in Table I . To confirm that a negative result was due neither to excessive RNA degradation nor failure of extraction, a similar length of mRNA transcript from the ubiquitously expressed ,B-actin gene was used as a reporter target for amplification (Figure 4 ). Actin mRNA was detected in all 43 tumours. None of the 32 control tissues (12 normal thyroids and 20 breast tumours/normal breast)
showed RET activation.
Discussion
In this study we have shown that is is possible to extract RNA from single sections of paraffin wax-embedded archival material and to demonstrate gene expression by using primers chosen for different exons and so generating a PCR product spanning an intron. Thyroid follicular cells do not normally express RET (Fabien et al., 1992) . However thyroid papillary carcinoma, a tumour derived from the follicular cell, shows RET activation through rearrangement, initially described with H4 to give an oncogene now designated RET/PTCI (Grieco et al., 1990; Pierotti et al., 1992) , but later described with two additional rearrangements, with a further rearrangement yet to be characterised (Bongarzone et al., 1993; Santoro et al., 1994 three rearrangements together formed only 34% of the papillary carcinomas studied. This is considerably less than the 56% of adults in our study, and significantly (P<0.05) less than the 23/40 (53.5%) in the combined adults and children. Our previous study of 15 different papillary carcinomas found that six (40%), showed PTCJ, again higher than the Italian series, in which 19% of the tumours showed PTCJ.
We are therefore detecting a slightly higher proportion of RET TK expression than the proportion of cases shown to be due to RET rearrangements in other studies. The discrepancy is not large, and we have excluded the possibility that it is due to expression by C cells. Studies of larger numbers by both our techniques using RET TK expression and the separate identification of each of the known RET translocations are needed to determine whether there are a significant number of cases with either unidentified RET rearrangements or overexpression of RET from other mechanisms such as gene amplification. It is also possible that the Southern blot identification of rearrangements is relatively insensitive in cases with a high stromal component. Both approaches agree that there is a significant proportion of papillary carcinomas that lack evidence of RET involvement, a minority of these seem to be due to TRK rearrangements, other translocations may yet remain to be identified. The studies of childhood thyroid carcinoma show that the proportion of cases with RET expression by RT-nPCR is similar to that in UK adults. Ito et al. (1994) reported that of 20 cases of childhood thyroid papillary carcinoma from the Chernobyl area, four out of the seven that could be successfully analysed showed the PTCJ translocation using RT-PCR. The observation was interpreted as suggesting that the translocation might be related to the radiation exposure. However no studies of control children were reported. The proportion of positives was very similar to that which we found by RT-nPCR of PTCJ in non-irradiated adults and less than that found for RET expression by RT-nPCR in non-irradiated children. The relationship of RET activation to radiation exposure therefore remains to be proven.
The RT-nPCR method adopted in this study is potentially of major importance in the elucidation of molecular pathological mechanisms because it illustrates the possibility of detecting a range of biologically interesting messenger RNA molecules from single sections of paraffin waxembedded formalin-fixed tissue. This allows the biological significance of newly discovered genes to be explored rapidly even for rare tumours as in this study of childhood thyroid tumours where tissue was analysed from blocks collected over a 30 year period. Large retrospective studies can also be performed. The method is particularly applicable to determining the biological role of the recently discovered chromosomal rearrangements/translocations giving rise to chimeric fusion transcripts in a variety of solid tumours (Galili et al., 1993; Crozat et al., 1993; Zucman et al., 1993; Schoenmakers et al., 1995) . Studies of these translocations have usually been performed on only small numbers of tumours because of the requirement for fresh tissue for standard molecular biological studies. This method can be applied to the large numbers of tumours in pathology department archives allowing, for example, correlation of translocations with morphological diagnosis, response to therapy and survival.
